Meet The Team
Chief Executive Officer
Chief Medical Officer
Eric Berreklouw (Chief Medical Officer) is the inventor of the AnchorValve technology. Dr Berreklouw practised as a cardiac surgeon for 40 years, holds several patents related to heart valve prostheses, and has extensive experience with research into sutureless heart valve prostheses.
Business Development Advisor
John McKenna (Business Development Advisor) is Director of Clinical Marketing at Aortech, with 30 years of experience with cardiac surgery manufacturers, including Vascutek and start up companies.
VP Regulatory and Clinical Affairs
Peter Duijst (Regulatory and Clinical Affairs) has over 25 years of experience in bringing cardiovascular devices to market. Amongst these were devices related to endovascular repair (EVT), and more recently transcatheter heart valve replacement (JenaValve), and rapid deployment aortic valve replacement (Edwards).
Nicolas van Mieghem
Member Scientific Advisory Board
Nicolas van Mieghem is an experienced and well recognized invasive cardiologist and researcher at the Thoraxcenter University Medical Center, Rotterdam, The Netherlands with broad experience with transcatheter treatment of valvular heart diseases.